Related Experiment Videos
Myocardial overexpression of adrenergic receptors and receptor kinases
W J Koch1, R J Lefkowitz, C A Milano
1Department of Surgery, Howard Hughes Medical Institute, Duke University Medical Center, Durham, North Carolina 27710, USA.
Advances in Pharmacology (San Diego, Calif.)
|November 5, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Mitral valve repair for ischemic mitral regurgitation: review of current techniques.
Heart, lung and vessels·2013
Institutional response to FDA warning on aprotinin and impact on outcomes.
HSR proceedings in intensive care & cardiovascular anesthesia·2013
Regulation of myocardial contractility: Insights from transgenic mice.
Trends in cardiovascular medicine·2011
Hypertension and albuminuria in chronic kidney disease mapped to a mouse chromosome 11 locus.
Kidney international·2007
Defects in cardiomyocyte function: role of beta-adrenergic receptor dysfunction.
Panminerva medica·2006
T Cell subsets for therapy-unconventional CD1d-restricted natural killer T cells.
Advances in pharmacology (San Diego, Calif.)·2026
Tracking therapeutic T cells in vivo.
Advances in pharmacology (San Diego, Calif.)·2026
In vivo transduction of CAR T cells: Pharmacological principles, delivery platforms, and the road to clinical translation.
Advances in pharmacology (San Diego, Calif.)·2026
Transient T cell therapies.
Advances in pharmacology (San Diego, Calif.)·2026
Manufacturing as biology: How T-cell processing shapes therapeutic outcomes.
Advances in pharmacology (San Diego, Calif.)·2026
Engineering T cell metabolism to enhance therapeutic efficacy.
Advances in pharmacology (San Diego, Calif.)·2026
A Systematic Intracranial Exposure-Response Evaluation of Brain-Penetrant Inhibitors: Informing Dose Selection for Brain Metastases.
Clinical and translational science·2026
Targeting Vascular Smooth Muscle Cell Senescence for Cardiovascular Pharmacology: Mechanisms and Therapeutic Perspectives.
Journal of cardiovascular pharmacology·2026
Insights into the degradation behaviour of tucatinib under stress conditions using liquid chromatography high resolution tandem mass spectrometry.
Analytical methods : advancing methods and applications·2026
Engineered dual RNAi prodrug for combined suppression of survival and cell cycle pathways in triple negative breast cancer treatment.
Chemical communications (Cambridge, England)·2026
Harnessing Functionalized Nano Lipid Carriers for Cardioprotection: Dual Drug Delivery in Focus for Precision Therapeutics.
Drug development and industrial pharmacy·2026